1 Supply Summary

• 1.1 Hyperimmune Globulin Injection Introduction
• 1.2 World Hyperimmune Globulin Injection Supply & Forecast
  • 1.2.1 World Hyperimmune Globulin Injection Production Value (2018 & 2022 & 2029)
  • 1.2.2 World Hyperimmune Globulin Injection Production (2018-2029)
  • 1.2.3 World Hyperimmune Globulin Injection Pricing Trends (2018-2029)
• 1.3 World Hyperimmune Globulin Injection Production by Region (Based on Production Site)
  • 1.3.1 World Hyperimmune Globulin Injection Production Value by Region (2018-2029)
  • 1.3.2 World Hyperimmune Globulin Injection Production by Region (2018-2029)
  • 1.3.3 World Hyperimmune Globulin Injection Average Price by Region (2018-2029)
  • 1.3.4 North America Hyperimmune Globulin Injection Production (2018-2029)
  • 1.3.5 Europe Hyperimmune Globulin Injection Production (2018-2029)
  • 1.3.6 China Hyperimmune Globulin Injection Production (2018-2029)
  • 1.3.7 Japan Hyperimmune Globulin Injection Production (2018-2029)
• 1.4 Market Drivers, Restraints and Trends
  • 1.4.1 Hyperimmune Globulin Injection Market Drivers
  • 1.4.2 Factors Affecting Demand
  • 1.4.3 Hyperimmune Globulin Injection Major Market Trends
• 1.5 Influence of COVID-19 and Russia-Ukraine War
  • 1.5.1 Influence of COVID-19
  • 1.5.2 Influence of Russia-Ukraine War

2 Demand Summary

• 2.1 World Hyperimmune Globulin Injection Demand (2018-2029)
• 2.2 World Hyperimmune Globulin Injection Consumption by Region
  • 2.2.1 World Hyperimmune Globulin Injection Consumption by Region (2018-2023)
  • 2.2.2 World Hyperimmune Globulin Injection Consumption Forecast by Region (2024-2029)
• 2.3 United States Hyperimmune Globulin Injection Consumption (2018-2029)
• 2.4 China Hyperimmune Globulin Injection Consumption (2018-2029)
• 2.5 Europe Hyperimmune Globulin Injection Consumption (2018-2029)
• 2.6 Japan Hyperimmune Globulin Injection Consumption (2018-2029)
• 2.7 South Korea Hyperimmune Globulin Injection Consumption (2018-2029)
• 2.8 ASEAN Hyperimmune Globulin Injection Consumption (2018-2029)
• 2.9 India Hyperimmune Globulin Injection Consumption (2018-2029)

3 World Hyperimmune Globulin Injection Manufacturers Competitive Analysis

• 3.1 World Hyperimmune Globulin Injection Production Value by Manufacturer (2018-2023)
• 3.2 World Hyperimmune Globulin Injection Production by Manufacturer (2018-2023)
• 3.3 World Hyperimmune Globulin Injection Average Price by Manufacturer (2018-2023)
• 3.4 Hyperimmune Globulin Injection Company Evaluation Quadrant
• 3.5 Industry Rank and Concentration Rate (CR)
  • 3.5.1 Global Hyperimmune Globulin Injection Industry Rank of Major Manufacturers
  • 3.5.2 Global Concentration Ratios (CR4) for Hyperimmune Globulin Injection in 2022
  • 3.5.3 Global Concentration Ratios (CR8) for Hyperimmune Globulin Injection in 2022
• 3.6 Hyperimmune Globulin Injection Market: Overall Company Footprint Analysis
  • 3.6.1 Hyperimmune Globulin Injection Market: Region Footprint
  • 3.6.2 Hyperimmune Globulin Injection Market: Company Product Type Footprint
  • 3.6.3 Hyperimmune Globulin Injection Market: Company Product Application Footprint
• 3.7 Competitive Environment
  • 3.7.1 Historical Structure of the Industry
  • 3.7.2 Barriers of Market Entry
  • 3.7.3 Factors of Competition
• 3.8 New Entrant and Capacity Expansion Plans
• 3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World

• 4.1 United States VS China: Hyperimmune Globulin Injection Production Value Comparison
  • 4.1.1 United States VS China: Hyperimmune Globulin Injection Production Value Comparison (2018 & 2022 & 2029)
  • 4.1.2 United States VS China: Hyperimmune Globulin Injection Production Value Market Share Comparison (2018 & 2022 & 2029)
• 4.2 United States VS China: Hyperimmune Globulin Injection Production Comparison
  • 4.2.1 United States VS China: Hyperimmune Globulin Injection Production Comparison (2018 & 2022 & 2029)
  • 4.2.2 United States VS China: Hyperimmune Globulin Injection Production Market Share Comparison (2018 & 2022 & 2029)
• 4.3 United States VS China: Hyperimmune Globulin Injection Consumption Comparison
  • 4.3.1 United States VS China: Hyperimmune Globulin Injection Consumption Comparison (2018 & 2022 & 2029)
  • 4.3.2 United States VS China: Hyperimmune Globulin Injection Consumption Market Share Comparison (2018 & 2022 & 2029)
• 4.4 United States Based Hyperimmune Globulin Injection Manufacturers and Market Share, 2018-2023
  • 4.4.1 United States Based Hyperimmune Globulin Injection Manufacturers, Headquarters and Production Site (States, Country)
  • 4.4.2 United States Based Manufacturers Hyperimmune Globulin Injection Production Value (2018-2023)
  • 4.4.3 United States Based Manufacturers Hyperimmune Globulin Injection Production (2018-2023)
• 4.5 China Based Hyperimmune Globulin Injection Manufacturers and Market Share
  • 4.5.1 China Based Hyperimmune Globulin Injection Manufacturers, Headquarters and Production Site (Province, Country)
  • 4.5.2 China Based Manufacturers Hyperimmune Globulin Injection Production Value (2018-2023)
  • 4.5.3 China Based Manufacturers Hyperimmune Globulin Injection Production (2018-2023)
• 4.6 Rest of World Based Hyperimmune Globulin Injection Manufacturers and Market Share, 2018-2023
  • 4.6.1 Rest of World Based Hyperimmune Globulin Injection Manufacturers, Headquarters and Production Site (State, Country)
  • 4.6.2 Rest of World Based Manufacturers Hyperimmune Globulin Injection Production Value (2018-2023)
  • 4.6.3 Rest of World Based Manufacturers Hyperimmune Globulin Injection Production (2018-2023)

5 Market Analysis by Type

• 5.1 World Hyperimmune Globulin Injection Market Size Overview by Type: 2018 VS 2022 VS 2029
• 5.2 Segment Introduction by Type
  • 5.2.1 Hepatitis B Immunoglobulins
  • 5.2.2 Rabies Immunoglobulins
  • 5.2.3 Tetanus Immunoglobulins
  • 5.2.4 Rho(D) Immunoglobulins
  • 5.2.5 Other
• 5.3 Market Segment by Type
  • 5.3.1 World Hyperimmune Globulin Injection Production by Type (2018-2029)
  • 5.3.2 World Hyperimmune Globulin Injection Production Value by Type (2018-2029)
  • 5.3.3 World Hyperimmune Globulin Injection Average Price by Type (2018-2029)

6 Market Analysis by Application

• 6.1 World Hyperimmune Globulin Injection Market Size Overview by Application: 2018 VS 2022 VS 2029
• 6.2 Segment Introduction by Application
  • 6.2.1 Government Institution
  • 6.2.2 Private Sector
  • 6.2.3 Others
• 6.3 Market Segment by Application
  • 6.3.1 World Hyperimmune Globulin Injection Production by Application (2018-2029)
  • 6.3.2 World Hyperimmune Globulin Injection Production Value by Application (2018-2029)
  • 6.3.3 World Hyperimmune Globulin Injection Average Price by Application (2018-2029)

7 Company Profiles

• 7.1 CSL Behring
  • 7.1.1 CSL Behring Details
  • 7.1.2 CSL Behring Major Business
  • 7.1.3 CSL Behring Hyperimmune Globulin Injection Product and Services
  • 7.1.4 CSL Behring Hyperimmune Globulin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
  • 7.1.5 CSL Behring Recent Developments/Updates
  • 7.1.6 CSL Behring Competitive Strengths & Weaknesses
• 7.2 Grifols
  • 7.2.1 Grifols Details
  • 7.2.2 Grifols Major Business
  • 7.2.3 Grifols Hyperimmune Globulin Injection Product and Services
  • 7.2.4 Grifols Hyperimmune Globulin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
  • 7.2.5 Grifols Recent Developments/Updates
  • 7.2.6 Grifols Competitive Strengths & Weaknesses
• 7.3 Biotest
  • 7.3.1 Biotest Details
  • 7.3.2 Biotest Major Business
  • 7.3.3 Biotest Hyperimmune Globulin Injection Product and Services
  • 7.3.4 Biotest Hyperimmune Globulin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
  • 7.3.5 Biotest Recent Developments/Updates
  • 7.3.6 Biotest Competitive Strengths & Weaknesses
• 7.4 Kedrion
  • 7.4.1 Kedrion Details
  • 7.4.2 Kedrion Major Business
  • 7.4.3 Kedrion Hyperimmune Globulin Injection Product and Services
  • 7.4.4 Kedrion Hyperimmune Globulin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
  • 7.4.5 Kedrion Recent Developments/Updates
  • 7.4.6 Kedrion Competitive Strengths & Weaknesses
• 7.5 CBPO
  • 7.5.1 CBPO Details
  • 7.5.2 CBPO Major Business
  • 7.5.3 CBPO Hyperimmune Globulin Injection Product and Services
  • 7.5.4 CBPO Hyperimmune Globulin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
  • 7.5.5 CBPO Recent Developments/Updates
  • 7.5.6 CBPO Competitive Strengths & Weaknesses
• 7.6 Emergent (Cangene)
  • 7.6.1 Emergent (Cangene) Details
  • 7.6.2 Emergent (Cangene) Major Business
  • 7.6.3 Emergent (Cangene) Hyperimmune Globulin Injection Product and Services
  • 7.6.4 Emergent (Cangene) Hyperimmune Globulin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
  • 7.6.5 Emergent (Cangene) Recent Developments/Updates
  • 7.6.6 Emergent (Cangene) Competitive Strengths & Weaknesses
• 7.7 Kamada
  • 7.7.1 Kamada Details
  • 7.7.2 Kamada Major Business
  • 7.7.3 Kamada Hyperimmune Globulin Injection Product and Services
  • 7.7.4 Kamada Hyperimmune Globulin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
  • 7.7.5 Kamada Recent Developments/Updates
  • 7.7.6 Kamada Competitive Strengths & Weaknesses
• 7.8 CNBG
  • 7.8.1 CNBG Details
  • 7.8.2 CNBG Major Business
  • 7.8.3 CNBG Hyperimmune Globulin Injection Product and Services
  • 7.8.4 CNBG Hyperimmune Globulin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
  • 7.8.5 CNBG Recent Developments/Updates
  • 7.8.6 CNBG Competitive Strengths & Weaknesses
• 7.9 Hualan Bio
  • 7.9.1 Hualan Bio Details
  • 7.9.2 Hualan Bio Major Business
  • 7.9.3 Hualan Bio Hyperimmune Globulin Injection Product and Services
  • 7.9.4 Hualan Bio Hyperimmune Globulin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
  • 7.9.5 Hualan Bio Recent Developments/Updates
  • 7.9.6 Hualan Bio Competitive Strengths & Weaknesses
• 7.10 Shanghai RAAS
  • 7.10.1 Shanghai RAAS Details
  • 7.10.2 Shanghai RAAS Major Business
  • 7.10.3 Shanghai RAAS Hyperimmune Globulin Injection Product and Services
  • 7.10.4 Shanghai RAAS Hyperimmune Globulin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
  • 7.10.5 Shanghai RAAS Recent Developments/Updates
  • 7.10.6 Shanghai RAAS Competitive Strengths & Weaknesses
• 7.11 Sichuan Yuanda Shuyang
  • 7.11.1 Sichuan Yuanda Shuyang Details
  • 7.11.2 Sichuan Yuanda Shuyang Major Business
  • 7.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Product and Services
  • 7.11.4 Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
  • 7.11.5 Sichuan Yuanda Shuyang Recent Developments/Updates
  • 7.11.6 Sichuan Yuanda Shuyang Competitive Strengths & Weaknesses
• 7.12 ADMA Biologics
  • 7.12.1 ADMA Biologics Details
  • 7.12.2 ADMA Biologics Major Business
  • 7.12.3 ADMA Biologics Hyperimmune Globulin Injection Product and Services
  • 7.12.4 ADMA Biologics Hyperimmune Globulin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
  • 7.12.5 ADMA Biologics Recent Developments/Updates
  • 7.12.6 ADMA Biologics Competitive Strengths & Weaknesses

8 Industry Chain Analysis

• 8.1 Hyperimmune Globulin Injection Industry Chain
• 8.2 Hyperimmune Globulin Injection Upstream Analysis
  • 8.2.1 Hyperimmune Globulin Injection Core Raw Materials
  • 8.2.2 Main Manufacturers of Hyperimmune Globulin Injection Core Raw Materials
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis
• 8.5 Hyperimmune Globulin Injection Production Mode
• 8.6 Hyperimmune Globulin Injection Procurement Model
• 8.7 Hyperimmune Globulin Injection Industry Sales Model and Sales Channels
  • 8.7.1 Hyperimmune Globulin Injection Sales Model
  • 8.7.2 Hyperimmune Globulin Injection Typical Customers

9 Research Findings and Conclusion

10 Appendix

• 10.1 Methodology
• 10.2 Research Process and Data Source

The global Hyperimmune Globulin Injection market size is expected to reach $ 2866.8 million by 2029, rising at a market growth of 5.9% CAGR during the forecast period (2023-2029).
Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
This report studies the global Hyperimmune Globulin Injection production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Hyperimmune Globulin Injection, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hyperimmune Globulin Injection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Hyperimmune Globulin Injection total production and demand, 2018-2029, (K Units)
Global Hyperimmune Globulin Injection total production value, 2018-2029, (USD Million)
Global Hyperimmune Globulin Injection production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Hyperimmune Globulin Injection consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Hyperimmune Globulin Injection domestic production, consumption, key domestic manufacturers and share
Global Hyperimmune Globulin Injection production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Hyperimmune Globulin Injection production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Hyperimmune Globulin Injection production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Hyperimmune Globulin Injection market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG and Hualan Bio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hyperimmune Globulin Injection market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Hyperimmune Globulin Injection Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Hyperimmune Globulin Injection Market, Segmentation by Type
Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Rho(D) Immunoglobulins
Other
Global Hyperimmune Globulin Injection Market, Segmentation by Application
Government Institution
Private Sector
Others
Companies Profiled:
CSL Behring
Grifols
Biotest
Kedrion
CBPO
Emergent (Cangene)
Kamada
CNBG
Hualan Bio
Shanghai RAAS
Sichuan Yuanda Shuyang
ADMA Biologics
Key Questions Answered
1. How big is the global Hyperimmune Globulin Injection market?
2. What is the demand of the global Hyperimmune Globulin Injection market?
3. What is the year over year growth of the global Hyperimmune Globulin Injection market?
4. What is the production and production value of the global Hyperimmune Globulin Injection market?
5. Who are the key producers in the global Hyperimmune Globulin Injection market?
6. What are the growth factors driving the market demand?